Adjustment With Aphasia After Stroke: SUPERB (SUPERB)

July 21, 2020 updated by: City, University of London

Adjustment Post Stroke and Aphasia: Supporting Psychological Wellbeing Through Peer Befriending

Aims: This exploratory trial will:

  1. Explore the feasibility of a definitive/phase III RCT on clinical and cost-effectiveness of peer-befriending for people with aphasia post-stroke.
  2. Investigate psychological and social wellbeing outcomes of participants, significant others, and peer befrienders.
  3. Explore the feasibility of a full economic evaluation of usual care + peer befriending versus usual care control.

Design: Single blind, mixed methods, parallel group phase II RCT comparing usual care + peer-befriending vs. usual care, starting at discharge from hospital. The study will deliver on four work packages: development phase; RCT; qualitative study; economic evaluation. Participants (n=60) will be assessed three times up to 10 months post-randomisation.

Outcome measures: Feasibility: feasibility of recruitment to definitive trial (proportion screened who meet criteria; proportion who consent; rate of consent); participant, significant other, peer befriender views on acceptability of procedures (qualitative study); number of missing/incomplete data on outcome measures; attrition rate at follow-up; potential value of conducting main trial using value of information analysis (economic evaluation); description of usual care; treatment fidelity of peer-befriending. Patient-reported outcomes will include mood, wellbeing, communication and social participation.

Benefits: Peer befriending may help avert some of the serious psychological consequences of stroke, and prevent the need for more complex and costly psychological therapies.

Study Overview

Status

Completed

Conditions

Detailed Description

Background: Stroke and aphasia can have a profound impact on people's lives. Depression is a common sequel of stroke, with rates remaining high even one year after stroke at 33%. It is associated with worse rehabilitation outcomes, increased carer strain, increased healthcare utilisation, and higher mortality. A recent audit of clinical psychology services for people with mood problems post-stroke across 10 UK stroke services found that the most common outcome of mood assessment was monitoring and advice, with less than half of patients with low mood receiving psychological intervention. There is a pressing need to evaluate systematically interventions that aim to improve psychosocial wellbeing for people with stroke and aphasia.

Aims: SUPERB trial aims to evaluate the feasibility of a phase III trial on the clinical and cost-effectiveness of a stepped care model level 1 intervention, peer befriending, for people with aphasia. Specifically it will:

  1. Explore the feasibility of a definitive phase III randomised control trial (RCT) based on a) feasibility of recruitment and retention to the trial, b) acceptability of research procedures and outcome measures, c) acceptability of usual care + peer befriending vs. usual care control to participants, their significant others and peer support workers, d) documentation of usual care, e) treatment fidelity of peer befriending.
  2. Explore psychological and social well-being outcomes as outcomes in a definitive trial for a) people with aphasia receiving usual care + peer befriending versus usual care control, b) their significant others, and c) peer befrienders.
  3. Explore the feasibility of a full economic evaluation of usual care + peer befriending versus usual care control in a phase III RCT.

Intervention to be tested: The intervention group will receive peer befriending from stroke survivors with long-term aphasia who will be trained as peer befrienders. They will visit participants who have had a stroke more recently 6 times over a period of 3 months. An further 2 visits within the next 6 months will also be offered for a gradual transition to the end of the peer befriending. The schedule and nature of visits will be agreed between the pair at their first meeting. This meeting will also identify possible goals for the intervention e.g. to offer conversation, help with problem solving and social activities.

Methods: The overall study will last 3½ years and comprise a development phase (year 1) and a phase II RCT (years 2-3). The development phase will inform the intervention manual, the choice of outcome measures, fidelity practices and topic guides for participant interviews. This phase will be informed through a series of six workshops attended by six people with aphasia with experience of peer befriending. This will be followed by a pilot of the intervention, fidelity checking and all associated processes with 8 participants comparing usual care (n=4) with usual care + peer befriending (n=4).

The phase II RCT will be a single blind, mixed methods, parallel group design comparing usual care (n=30) with usual care + peer befriending (n=30) for people with aphasia post-stroke and low levels of psychological problems. Assessments and outcome measures for participants and significant others will be administered before randomisation with outcome measures re-administered at 4 and 10 months post-randomisation. Peer befrienders will complete outcome measures before training and after they have completed the visits for two participants. In addition, this RCT will include a qualitative study and a feasibility economic evaluation. The qualitative study will use semi-structured interviews of purposively sampled participants (n=20) and significant others (n=10) from both arms of the trial, and peer befrienders. The feasibility economic evaluation will utilise the EQ-5D and a stroke-adapted version of the CSRI.

Outcomes: RCT: feasibility of recruitment of participants to definitive trial (including proportion screened who meet criteria; proportion who consent; rate of consent); number of missing/incomplete data on outcome measures; attrition rate at follow-up; potential value of conducting main trial using value of information analysis (economic evaluation); description of usual care; treatment fidelity of peer befriending. Patient-reported outcomes will include mood, wellbeing, communication and social participation. Qualitative study: participant, significant other, peer befriender views on acceptability of procedures and experiences of care received. Economic evaluation: cost outcomes, average costs, costs per participant and mean difference between trial arms, description of resources used and overall cost effectiveness.

Benefits: This study will inform on whether peer befriending is a suitable intervention to explore further, in terms of averting some of the serious psychological consequences of stroke, and preventing the need for more complex and costly psychological therapies.

Study Type

Interventional

Enrollment (Actual)

62

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • London, United Kingdom, E1 1BB
        • The Royal London Hospital
      • London, United Kingdom, NW3 2QG
        • The Royal Free Hospital
      • London, United Kingdom, NW1 2BU
        • University College London Hospital
      • London, United Kingdom, E9 6SR
        • Homerton University Hospital
      • London, United Kingdom, WC1N 3BG
        • The National Hospital for Neurology and Neurosurgery

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Participants with aphasia:

  • Over 18;
  • Fluent premorbid users of English (confirmed by relative or self report);
  • Presence of aphasia due to stroke; and
  • Low levels of emotional distress (score of ≤2 on Depression Intensity Scale Circles). The latter will ensure that they do not require immediate level 2 or 3 psychological input. People who score 2 (which is also the median on DISCS) and who the MDT deems do not need stepping up or stepping up is not available, will still be eligible to take part.

Significant Others: each participant with aphasia will nominate one significant other, who is their closest confidant and who is over 18 years of age. If participants live alone their significant other should be someone that they see at least once a week.

Peer befrienders: will be people with mild-moderate aphasia (score score a minimum 5/10 for auditory comprehension and 5/10 for verbal expression in the Frenchay Aphasia Screening Test) who are over 18 years of age, are at least one year post-stroke

Exclusion Criteria:

Participants will be excluded if they have:

  • Other diagnoses affecting cognition or mental health (based on medical records for participants with aphasia and self-report for significant others and peer befrienders, as well as the GHQ-12 as a depression screen for peer befrienders: will be excluded if they score 3 or more);
  • Severe uncorrected visual or hearing problems (based on medical records for participants with aphasia and self-report for significant others and peer befrienders);
  • Severe or potentially terminal co-morbidities, on grounds of frailty (based on medical records for participants with aphasia and self-report for significant others and peer befrienders).

Participants with aphasia will also be excluded if they are:

• Discharged to a geographical location outside the borough of the recruiting hospital.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: USUAL
Usual care
The control group will receive usual care, i.e. all health, social care and voluntary services available to them in their borough. It is not known what exactly usual care comprises for people with aphasia who are discharged in the community with low levels of psychological problems, and this project will help to document this.
Experimental: PEER
Usual care + peer-befriending
The control group will receive usual care, i.e. all health, social care and voluntary services available to them in their borough. It is not known what exactly usual care comprises for people with aphasia who are discharged in the community with low levels of psychological problems, and this project will help to document this.
The experimental group will receive usual care + peer befriending. Peer befriending aims to utilise the skills and 'lived experience' of people with longer-term aphasia to offer support to others with aphasia, starting at a time of transition (discharge from hospital and withdrawal of intensive therapeutic input) and increased need. It aims to help people develop their own strategies for adjusting to life post-stroke. Peer-befrienders will visit participants 6 times over a period of 3 months (+2 times within the next 6 months). The schedule, nature of visits, and goals (e.g. discuss concerns; pursue activities) will be agreed between the pair. Visits may include: conversation, problem solving, trips out, joint activities.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
General Health Questionnaire-12 (GHQ-12) continuous total score
Time Frame: 4 months post randomisation
For participants with aphasia.
4 months post randomisation
Depression Intensity Scale Circles (DISCS) continuous total score
Time Frame: 4 months post randomisation
The DISCS will be treated as the primary outcome measure only if there is ≥10% missing data in the GHQ-12 due to severity of aphasia, otherwise it will be a secondary outcome measure.
4 months post randomisation
General Health Questionnaire-12 (GHQ-12) continuous total score
Time Frame: 10 months post randomisation
For participants with aphasia.
10 months post randomisation
Depression Intensity Scale Circles (DISCS) continuous total score
Time Frame: 10 months post randomisation
The DISCS will be treated as the primary outcome measure only if there is ≥10% missing data in the GHQ-12 due to severity of aphasia, otherwise it will be a secondary outcome measure.
10 months post randomisation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Short Warwick Edinburgh Mental Well-being Scale (SWEMWBS) continuous total score.
Time Frame: 4 months post randomisation
For participants with aphasia.
4 months post randomisation
Short Warwick Edinburgh Mental Well-being Scale (SWEMWBS) continuous total score.
Time Frame: 10 months post randomisation
For participants with aphasia.
10 months post randomisation
Communicative Participation Item Bank (CPIB) continuous total score
Time Frame: 4 months post randomisation
For participants with aphasia.
4 months post randomisation
Communicative Participation Item Bank (CPIB) continuous total score
Time Frame: 10 months post randomisation
For participants with aphasia.
10 months post randomisation
Community Integration Questionnaire (CIQ) continuous total score
Time Frame: 4 months post randomisation
For participants with aphasia.
4 months post randomisation
Community Integration Questionnaire (CIQ) continuous total score
Time Frame: 10 months post randomisation
For participants with aphasia.
10 months post randomisation
Proportion with high emotional distress vs low emotional distress as measured using the GHQ-12 (high distress = score of 3 or more, low distress = score of 0-2)
Time Frame: 4 months post randomisation
For participants with aphasia.
4 months post randomisation
Proportion with high emotional distress vs low emotional distress as measured using the GHQ-12 (high distress = score of 3 or more, low distress = score of 0-2)
Time Frame: 10 months post randomisation
For participants with aphasia.
10 months post randomisation
Warwick Edinburgh Mental Well-being Scale (WEMWBS) continuous total score
Time Frame: 4 months post randomisation
For significant others.
4 months post randomisation
Warwick Edinburgh Mental Well-being Scale (WEMWBS) continuous total score
Time Frame: 10 months post randomisation
For significant others.
10 months post randomisation
General Health Questionnaire-28 (GHQ-28) continuous total score. The GHQ-28 also provides four subscale scores (somatic symptoms, anxiety/insomnia, severe depression, and social dysfunction), which will be looked at descriptively.
Time Frame: 4 months post randomisation
For significant others.
4 months post randomisation
General Health Questionnaire-28 (GHQ-28) continuous total score. The GHQ-28 also provides four subscale scores (somatic symptoms, anxiety/insomnia, severe depression, and social dysfunction), which will be looked at descriptively.
Time Frame: 10 months post randomisation
For significant others.
10 months post randomisation
Bakas Caregiving Outcome Scale (BCOS) continuous total score
Time Frame: 4 months post randomisation
For significant others.
4 months post randomisation
Bakas Caregiving Outcome Scale (BCOS) continuous total score
Time Frame: 10 months post randomisation
For significant others.
10 months post randomisation
Warwick Edinburgh Mental Well-being Scale (WEMWBS) continuous total score
Time Frame: ~ 6 months
For peer befrienders. Outcomes will be assessed on completion of 2 befriending cycles
~ 6 months
Community Integration Questionnaire (CIQ) continuous total score
Time Frame: ~ 6 months
For peer befrienders. Outcomes will be assessed on completion of 2 befriending cycles
~ 6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Communication Confidence Rating Scale for people with aphasia (CCRSA)
Time Frame: 4 months post randomisation
Exploratory measure for participants with aphasia.
4 months post randomisation
Communication Confidence Rating Scale for people with aphasia (CCRSA)
Time Frame: 10 months post randomisation
Exploratory measure for participants with aphasia.
10 months post randomisation
Friendship Scale (FS)
Time Frame: 4 months post randomisation
Exploratory measure for participants with aphasia.
4 months post randomisation
Friendship Scale (FS)
Time Frame: 10 months post randomisation
Exploratory measure for participants with aphasia.
10 months post randomisation
EQ-5D-5L
Time Frame: 4 months post randomisation
Economic evaluation outcome.
4 months post randomisation
EQ-5D-5L
Time Frame: 10 months post randomisation
Economic evaluation outcome.
10 months post randomisation
Stroke adapted Client Service Receipt Inventory (CSRI)
Time Frame: 4 months post randomisation
Economic evaluation outcome.
4 months post randomisation
Stroke adapted Client Service Receipt Inventory (CSRI)
Time Frame: 10 months post randomisation
Economic evaluation outcome.
10 months post randomisation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Katerina Hilari, City, University of London

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 25, 2017

Primary Completion (Actual)

August 20, 2019

Study Completion (Actual)

August 20, 2019

Study Registration Dates

First Submitted

October 13, 2016

First Submitted That Met QC Criteria

October 26, 2016

First Posted (Estimate)

October 28, 2016

Study Record Updates

Last Update Posted (Actual)

July 22, 2020

Last Update Submitted That Met QC Criteria

July 21, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Anonymised data may be shared e.g. for meta-analyses

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on USUAL

Subscribe